13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q4 2020. See the latest, Q2 2026 →
Reported value
$36.37B
+31% on the quarter before
Positions
96
25 new · 15 sold out
Top 10
39.2%
of the value
Est. gain
+$4.20B
on stocks held all quarter
Est. return
+20.7%
on those stocks since Q3 2020
Positions as of Dec 31, 2020, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 65% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2020. Striped tiles are options.
Largest buys
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$979.7MNew · 0.0% → 2.7%+2,793,665 shares
- Visa Inc.~$823.3MAdded · 0.2% → 2.5%+3,763,943 shares
- Microsoft~$796.5MAdded · 6.3% → 7.2%+3,581,072 shares
- Abcellera Biologics Inc~$776.0MNew · 0.0% → 2.1%+19,283,744 shares
- Walt Disney Company (The)~$773.9MNew · 0.0% → 2.1%+4,271,505 shares
- Alphabet~$749.9MAdded · 1.0% → 3.0%+427,842 shares
- Palo Alto Networks~$670.7MNew · 0.0% → 1.8%+1,887,130 shares
- Fleetcor Technologies Inc~$491.1MAdded · 0.4% → 1.7%+1,799,953 shares
- ServiceNow~$422.8MNew · 0.0% → 1.2%+768,107 shares
- Fidelity Natl Information Sv~$417.2MAdded · 4.7% → 4.6%+2,948,891 shares
Largest sells
Since Q3 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- American Express Co~$680.0MCut · 3.9% → 1.7%−5,624,070 shares
- Thermo Fisher Scientific Inc~$605.2MCut · 2.2% → 0.1%−1,299,406 shares
- Comcast Corp New~$464.7MSold out · 1.7% → 0.0%−10,045,065 shares
- Hilton Worldwide Hldgs Inc~$457.5MCut · 2.7% → 1.4%−4,111,691 shares
- Cme Group Inc~$387.6MSold out · 1.4% → 0.0%−2,316,366 shares
- Booking Holdings Inc~$356.7MCut · 2.2% → 1.2%−160,167 shares
- Raytheon Technologies Corp~$353.7MSold out · 1.3% → 0.0%−6,147,033 shares
- Las Vegas Sands Corp~$343.5MCut · 1.4% → 0.5%−5,762,752 shares
- Analog Devices~$341.9MSold out · 1.2% → 0.0%−2,928,432 shares
- Exact Sciences Corp~$305.5MSold out · 1.1% → 0.0%−2,996,604 shares
Holdings
As of Dec 31, 2020. Changes are in shares against Sep 30, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +43% · price +5.7% | 7.2% | $2.63B | +$99.8M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price +89.5% | 5.2% | $1.89B | +$894.2M | ||||||||
| Adaptive Biotechnologies CorCOM · shares −10% · price +21.6% | 4.9% | $1.77B | +$314.9M | ||||||||
| Fidelity Natl Information SvCOM · shares +33% · price −3.9% | 4.6% | $1.67B | −$51.1M | ||||||||
| T-Mobile Us IncCOM · shares +7.9% · price +17.9% | 3.2% | $1.17B | +$165.4M | ||||||||
| AlphabetCAP STK CL A · shares +223% · price +19.6% | 3.0% | $1.09B | +$55.1M | ||||||||
| Boston Scientific CorpCOM · shares +59% · price −5.9% | 3.0% | $1.08B | −$42.6M | ||||||||
| Jpmorgan Chase & CoCOM · shares −10% · price +32.0% | 3.0% | $1.07B | +$260.5M | ||||||||
| Unitedhealth Group IncCOM · shares New | 2.7% | $979.7M | — | ||||||||
| Visa Inc.COM CL A · shares +1,170% · price +9.4% | 2.5% | $893.6M | +$6.0M | ||||||||
| Centene Corp DelCOM · shares −25% · price +2.9% | 2.2% | $785.7M | +$22.2M | ||||||||
| Abcellera Biologics IncCOM · shares New | 2.1% | $776.0M | — | ||||||||
| Walt Disney Company (The)COM · shares New | 2.1% | $773.9M | — | ||||||||
| Nuance Communications IncCOM · shares −3.5% · price +32.8% | 2.0% | $722.3M | +$178.6M | ||||||||
| MercadoLibreCOM · shares −13% · price +54.8% | 1.9% | $690.0M | +$244.2M | ||||||||
| Palo Alto NetworksCOM · shares New | 1.8% | $670.7M | — | ||||||||
| AmazonCOM · shares −26% · price +3.4% | 1.8% | $652.9M | +$21.7M | ||||||||
| American Express CoCOM · shares −52% · price +20.6% | 1.7% | $631.7M | +$107.9M | ||||||||
| Fleetcor Technologies IncCOM · shares +383% · price +14.6% | 1.7% | $619.3M | +$16.3M | ||||||||
| TSMCSPONSORED ADS · shares −8.9% · price +34.5% | 1.7% | $610.8M | +$156.7M | ||||||||
| Api Group CorpCOM STK · shares 0% · price +27.5% | 1.7% | $605.0M | +$130.7M | ||||||||
| Zimmer Biomet Holdings IncCOM · shares +129% · price +13.2% | 1.6% | $595.9M | +$30.3M | ||||||||
| Fortive CorpCOM · shares +17% · price −7.1% | 1.6% | $564.0M | −$36.7M | ||||||||
| Aon PlcSHS CL A · shares −15% · price +2.4% | 1.5% | $543.1M | +$12.8M | ||||||||
| Hilton Worldwide Hldgs IncCOM · shares −47% · price +30.4% | 1.4% | $525.1M | +$122.4M | ||||||||
| Total · 96 positions | 100% | $36.37B | +$4.20B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2020 to Q4 2020: 71 stocks held throughout, up $4.20B (+20.7%).
- Bridgebio Pharma Inc+$894.2M+90%
- Adaptive Biotechnologies Cor+$314.9M+22%
- Jpmorgan Chase & Co+$260.5M+32%
- MercadoLibre+$244.2M+55%
- Nuance Communications Inc+$178.6M+33%
- Pacific Biosciences Calif In1:3 split−$5.5M−12%
- Bristol-Myers Squibb Co−$13.8M−69%
- Fortive Corp−$36.7M−7%
- Boston Scientific Corp−$42.6M−6%
- Fidelity Natl Information Sv−$51.1M−4%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |